Kuhn P, Dillenseger L, Cojean N, Escande B, Zores C, Astruc D
Médecine et réanimation du nouveau-né, service de pédiatrie 2, CHU de Strasbourg, avenue Molière, 67000 Strasbourg, France.
Médecine et réanimation du nouveau-né, service de pédiatrie 2, CHU de Strasbourg, avenue Molière, 67000 Strasbourg, France.
Arch Pediatr. 2017 Feb;24(2):155-159. doi: 10.1016/j.arcped.2016.11.012. Epub 2016 Dec 29.
The 2005 enactment of the "Patients' rights and end-of-life care" act, known as the Leonetti law, has been accompanied by practical changes in the processes of withdrawal and withholding of active life-sustaining treatments. This law has also promoted the implementation of palliative care in perinatal medicine to avoid unreasonable therapeutic interventions and to preserve the dying patient's quality of life and human dignity. Recently, a new law has been voted by the French National Assembly and new reflections on the ethical aspects of the end of life in neonatal medicine should resume again within the French Society of Neonatology in the working group on ethical issues in neonatology. This is why it appears important to discuss the perceived benefits and the persistent difficulties related to the implementation of the Leonetti law in neonatology. Collegiality in the decision-making processes as well as withdrawal and withholding of life-sustaining treatments that were already present in the practices of many centers has been stipulated within a legal framework and promoted in clinical practice. It has brought serenity within perinatal nursing and medical teams. It has helped them face the always-difficult end-of-life situations with parents and deal with decision-making processes in an intense emotional climate. However, new questions inherent to the law have appeared. The most important ones concern the withholding of artificial nutrition and hydration, the time pressure in the management of the decision-making process, and the management of the duration of palliative care. Challenges remain in addressing various persistent ethical dilemmas such as the possible survival of newborns with significant brain lesions detected after the period of life-sustaining treatments that have allowed their survival. The new law carried by Mr. Clayes and Mr. Léonetti should provide answers to some of these ethical issues, but it would probably not solve all of them.
2005年颁布的“患者权利与临终关怀”法案,即众所周知的莱奥内蒂法,伴随着在撤除和停止积极维持生命治疗过程中的实际变化。该法律还推动了围产期医学中姑息治疗的实施,以避免不合理的治疗干预,并维护临终患者的生活质量和人的尊严。最近,法国国民议会通过了一项新法律,法国新生儿学会新生儿伦理问题工作组应再次对新生儿医学临终伦理方面进行新的思考。这就是为什么讨论莱奥内蒂法在新生儿医学实施中所带来的明显益处和持续存在的困难显得很重要。许多中心实践中已经存在的决策过程中的合议性以及维持生命治疗的撤除和停止,已在法律框架内得到规定并在临床实践中得到推广。它给围产期护理和医疗团队带来了平静。它帮助他们面对与父母在一起时总是艰难的临终情况,并在激烈的情感氛围中处理决策过程。然而,该法律固有的新问题出现了。最重要的问题涉及人工营养和水分的停止、决策过程管理中的时间压力以及姑息治疗持续时间的管理。在应对各种持续存在的伦理困境方面仍然存在挑战,例如在维持生命治疗使患有严重脑损伤的新生儿存活之后检测到他们可能存活的情况。克莱斯先生和莱奥内蒂先生提出的新法律应该会对其中一些伦理问题给出答案,但可能无法解决所有问题。